pharmaceuticals-and-healthcare

Global Biologics and Biosimilars Market Research Report 2016


Published On : Sep 2016

Category : Biotechnology

No. of Pages : 121 pages

  • $2900
  • $5800

Please click below to avail discount on this report

This report studies Biologics and Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Biologics and Biosimilars in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Classification by Technology
Classification by Types
Classification by Use
Classification by Services
Split by application, this report focuses on consumption, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The Global biologics and biosimilars market research report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the Global biologics and biosimilars market research report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the Global biologics and biosimilars market research report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Type
1.2.1 Global Production Market Share of Biologics and Biosimilars by Type in 2015
1.2.2 Classification by Technology
1.2.3 Classification by Types
1.2.4 Classification by Use
1.2.5 Classification by Services
1.3 Biologics and Biosimilars Segment by Application
1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2015
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Biologics and Biosimilars Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Biologics and Biosimilars (2011-2021)

2 Global Biologics and Biosimilars Market Competition by Manufacturers
2.1 Global Biologics and Biosimilars Production and Share by Manufacturers (2015 and 2016)
2.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Biologics and Biosimilars Production, Revenue (Value) by Region (2011-2016)
3.1 Global Biologics and Biosimilars Production and Market Share by Region (2011-2016)
3.2 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Biologics and Biosimilars Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Biologics and Biosimilars Consumption by Regions (2011-2016)
4.2 North America Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type
5.1 Global Biologics and Biosimilars Production and Market Share by Type (2011-2016)
5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
5.3 Global Biologics and Biosimilars Price by Type (2011-2016)
5.4 Global Biologics and Biosimilars Production Growth by Type (2011-2016)

6 Global Biologics and Biosimilars Market Analysis by Application
6.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2011-2016)
6.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Biologics and Biosimilars Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Biologics and Biosimilars Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Roche
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Biologics and Biosimilars Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Amgen
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Biologics and Biosimilars Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 AbbVie
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Biologics and Biosimilars Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Sanofi
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Biologics and Biosimilars Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Biologics and Biosimilars Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Biologics and Biosimilars Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Novartis
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Biologics and Biosimilars Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Merck
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Biologics and Biosimilars Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Merck Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Lilly
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Biologics and Biosimilars Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Lilly Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 3sbio
7.12 Changchun high tech
7.13 CP Guojian Pharmacy
7.14 Biotech Pharma
7.15 Gelgen Biopharma
7.16 Sandoz
7.17 Teva
7.18 Hospira
7.19 Mylan
7.20 3sbio
7.21 Changchun high tech
7.22 CP Guojian Pharmacy
7.23 Biotech Pharma
7.24 Gelgen Biopharma

8 Biologics and Biosimilars Manufacturing Cost Analysis
8.1 Biologics and Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biologics and Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Biologics and Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Biologics and Biosimilars Market Forecast (2016-2021)
12.1 Global Biologics and Biosimilars Production, Revenue Forecast (2016-2021)
12.2 Global Biologics and Biosimilars Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Biologics and Biosimilars Production Forecast by Type (2016-2021)
12.4 Global Biologics and Biosimilars Consumption Forecast by Application (2016-2021).
12.5 Biologics and Biosimilars Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

Figure Picture of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Figure Product Picture of Classification by Technology
Table Major Manufacturers of Classification by Technology
Figure Product Picture of Classification by Types
Table Major Manufacturers of Classification by Types
Figure Product Picture of Classification by Use
Table Major Manufacturers of Classification by Use
Figure Product Picture of Classification by Services
Table Major Manufacturers of Classification by Services
Table Biologics and Biosimilars Consumption Market Share by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Biologics and Biosimilars Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Type
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Production by Regions (2011-2016)
Figure Global Biologics and Biosimilars Production and Market Share by Regions (2011-2016)
Figure Global Biologics and Biosimilars Production Market Share by Regions (2011-2016)
Figure 2015 Global Biologics and Biosimilars Production Market Share by Regions
Table Global Biologics and Biosimilars Revenue by Regions (2011-2016)
Table Global Biologics and Biosimilars Revenue Market Share by Regions (2011-2016)
Table 2015 Global Biologics and Biosimilars Revenue Market Share by Regions
Table Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Biologics and Biosimilars Consumption Market by Regions (2011-2016)
Table Global Biologics and Biosimilars Consumption Market Share by Regions (2011-2016)
Figure Global Biologics and Biosimilars Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Biologics and Biosimilars Consumption Market Share by Regions
Table North America Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table China Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table India Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Global Biologics and Biosimilars Production by Type (2011-2016)
Table Global Biologics and Biosimilars Production Share by Type (2011-2016)
Figure Production Market Share of Biologics and Biosimilars by Type (2011-2016)
Figure 2015 Production Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Revenue by Type (2011-2016)
Table Global Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Biologics and Biosimilars by Type (2011-2016)
Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Price by Type (2011-2016)
Figure Global Biologics and Biosimilars Production Growth by Type (2011-2016)
Table Global Biologics and Biosimilars Consumption by Application (2011-2016)
Table Global Biologics and Biosimilars Consumption Market Share by Application (2011-2016)
Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2015
Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Biologics and Biosimilars Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Biologics and Biosimilars Market Share (2011-2016)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Biologics and Biosimilars Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Biologics and Biosimilars Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Biologics and Biosimilars Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Biologics and Biosimilars Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Biologics and Biosimilars Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Biologics and Biosimilars Market Share (2011-2016)
Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lilly Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lilly Biologics and Biosimilars Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Biologics and Biosimilars Production Forecast by Regions (2016-2021)
Table Global Biologics and Biosimilars Consumption Forecast by Regions (2016-2021)
Table Global Biologics and Biosimilars Production Forecast by Type (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top